Dr. Kevin Thompson, DO

NPI: 1164587119
Total Payments
$101,034
2024 Payments
$1,169
Companies
53
Transactions
670
Medicare Patients
9,275
Medicare Billing
$1.7M

Payment Breakdown by Category

Other$75,305 (74.5%)
Food & Beverage$11,607 (11.5%)
Education$9,833 (9.7%)
Travel$4,290 (4.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,305 45 74.5%
Food and Beverage $11,607 583 11.5%
Education $9,833 21 9.7%
Travel and Lodging $4,290 21 4.2%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $81,744 148 $0 (2024)
AngioDynamics, Inc. $9,600 4 $0 (2020)
Novartis Pharmaceuticals Corporation $1,715 119 $0 (2024)
Boston Scientific Corporation $1,288 14 $0 (2024)
E.R. Squibb & Sons, L.L.C. $860.79 54 $0 (2024)
PFIZER INC. $848.05 54 $0 (2024)
AstraZeneca Pharmaceuticals LP $785.28 47 $0 (2024)
Janssen Pharmaceuticals, Inc $497.36 47 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $375.10 19 $0 (2024)
Merck Sharp & Dohme LLC $361.41 18 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,169 62 PFIZER INC. ($311.52)
2023 $8,472 85 Amgen Inc. ($7,080)
2022 $8,751 88 Amgen Inc. ($7,247)
2021 $10,061 73 Amgen Inc. ($8,825)
2020 $14,575 61 Amgen Inc. ($11,610)
2019 $11,759 111 Amgen Inc. ($8,173)
2018 $38,283 100 Amgen Inc. ($35,111)
2017 $7,963 90 Amgen Inc. ($3,636)

All Payment Transactions

670 individual payment records from CMS Open Payments — Page 1 of 27

Date Company Product Nature Form Amount Type
12/12/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $18.44 General
Category: CARDIOVASCULAR
12/11/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $21.30 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/05/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $26.83 General
Category: CARDIOVASCULAR
11/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.86 General
Category: DIABETES
11/18/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $18.28 General
Category: Cardiology/Vascular Diseases
11/14/2024 Medtronic, Inc. COBALT DR MRI SURESCAN (Device) Food and Beverage In-kind items and services $15.69 General
Category: Implantable Cardioverter Defibrillators (ICDs)
11/06/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $19.81 General
Category: Cardiology
10/29/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $27.50 General
Category: CARDIOVASCULAR
10/22/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $20.23 General
Category: Cardiovascular
10/18/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $13.27 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/01/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $18.73 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/25/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.85 General
Category: Cardiovascular and Metabolism
09/19/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $16.49 General
Category: Cardiology/Vascular Diseases
09/18/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $26.00 General
Category: CARDIOVASCULAR
09/11/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $27.37 General
Category: Cardiovascular
09/10/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $17.50 General
Category: Electromedical and Electrotherapeutic Apparatus
09/06/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.99 General
Category: Inflammation
08/29/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $18.59 General
Category: Cardiology/Vascular Diseases
08/29/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $18.28 General
Category: Cardiology/Vascular Diseases
08/20/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $13.66 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/14/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $18.91 General
Category: Cardiovascular
08/06/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $58.24 General
Category: Cardiovascular Device
08/05/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $18.55 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/26/2024 Boston Scientific Corporation WATCHMAN Access System (Device) Food and Beverage In-kind items and services $17.07 General
Category: WATCHMAN_IC
07/25/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $18.28 General
Category: Cardiology/Vascular Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 2,098 3,304 $1.0M $367,420
2022 28 2,388 7,248 $1.2M $474,188
2021 26 2,534 3,780 $1.2M $456,994
2020 25 2,255 3,377 $1.1M $405,907
Total Patients
9,275
Total Services
17,709
Medicare Billing
$1.7M
Procedure Codes
105

All Medicare Procedures & Services

105 procedure records from CMS Medicare Utilization — Page 5 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 14 14 $5,474 $1,545 28.2%
93284 Evaluation, testing and programming adjustment of defibrillator with analysis, review and report Office 2020 16 22 $5,830 $1,435 24.6%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 178 202 $8,282 $1,293 15.6%
93224 Heart rhythm tracing, analysis, and interpretation of 48-hour ekg Office 2020 22 23 $6,693 $1,274 19.0%
93283 Evaluation, testing and programming adjustment of defibrillator with analysis, review and report Office 2020 11 16 $3,824 $1,077 28.2%

About Dr. Kevin Thompson, DO

Dr. Kevin Thompson, DO is a Cardiovascular Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164587119.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Thompson, DO has received a total of $101,034 in payments from pharmaceutical and medical device companies, with $1,169 received in 2024. These payments were reported across 670 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,305).

As a Medicare-enrolled provider, Thompson has provided services to 9,275 Medicare beneficiaries, totaling 17,709 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Nuclear Cardiology, Interventional Cardiology
  • Location Salem, OR
  • Active Since 12/27/2006
  • Last Updated 07/11/2018
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1164587119

Products in Payments

  • Repatha (Biological) $81,331
  • EVLT (Device) $9,600
  • ENTRESTO (Drug) $1,380
  • ELIQUIS (Drug) $1,281
  • GENERAL - VASCULAR ACCESS (Device) $1,006
  • XARELTO (Drug) $497.36
  • Corlanor (Drug) $395.17
  • BRILINTA (Drug) $385.63
  • VERQUVO (Drug) $361.41
  • LEQVIO (Drug) $335.55
  • JARDIANCE (Drug) $291.45
  • Impella (Device) $269.32
  • Vascepa (Drug) $248.01
  • CAMZYOS (Drug) $224.07
  • FARXIGA (Drug) $215.97
  • LifeVest (Device) $212.65
  • VYNDAQEL (Drug) $196.73
  • SYMBICORT (Drug) $171.80
  • NEXLETOL (Drug) $161.52
  • WATCHMAN Access System (Device) $142.79

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Salem